CI Investments Inc. Sells 337 Shares of Alnylam Pharmaceutic

CI Investments Inc. lessened its position in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 11.3% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,648 shares of the biopharmaceutical company’s stock after selling 337 shares during the period. CI Investments Inc.’s holdings […]

Related Keywords

Canada , William Blair , Michaelw Bonney , Piper Sandler , Alnylam Pharmaceuticals Price Performance , Ci Investments Inc , Northwestern Mutual Wealth Management Co , Royal Bank , Needham Company , News Ratings For Alnylam Pharmaceuticals Daily , Alnylam Pharmaceuticals , Alnylam Pharmaceuticals Company Profile , Wells Fargo Company , Securities Exchange Commission , Alnylam Pharmaceuticals Inc , Kb Financial Partners , Quarter For Alnylam Pharmaceuticals , Bessemer Group Inc , First Capital Advisors Group , Financial Gravity Asset Management Inc , Nasdaq , Free Report , Gravity Asset Management , Mutual Wealth Management , Get Free Report , Director Michael , Wells Fargo , Alnylam Pharmaceuticals Daily , Nasdaq Alny , Dalny , Medical , 02043q10 , Sec Filings , 13f , Hedge Fund Holdings , Institutional Investor Holdings ,